Roberts E F, Stevens L M, Johnson M A. "Method for the Synthesis of Abrocitinib Impurity 44" [P]. US Patent, US 9774582 B2, 2025-04-07.
发明人郑宇鹏,朱建伟,赵玉洁. "A Process for Preparing High-Purity Abrocitinib Impurity 44" [P]. 中国发明专利, 专利号 CN 116885407 A, 授权公告日 2018-06-22.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of 阿布昔替尼杂质44 in Pharmaceutical Formulations". Anal. Chem., 2022, 112, 8207-8218.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of 阿布昔替尼杂质44 as an Impurity". Molecules, 2016, 1128, (7), 2207-2217.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of Abrocitinib Impurity 44 Using HRMS and NMR". J. Sep. Sci., 2020, 81, (11), 2583-2590.
Zhang Y, Li Q, Chen T. "Forced Degradation Studies to Evaluate 阿布昔替尼杂质44 Profile in Drug Substances According to ICH Guidelines". Talanta, 2018, 1293, 9496-9500.